These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11012292)

  • 21. [Enduringly effective and tolerable initial therapy of HIV. Even after 5 years no resistance].
    MMW Fortschr Med; 2003 Dec; 145(50):60-1. PubMed ID: 14963980
    [No Abstract]   [Full Text] [Related]  

  • 22. Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals.
    Mannheimer SB; Wold N; Gardner EM; Telzak EE; Huppler Hullsiek K; Chesney M; Wu AW; MacArthur RD; Matts J; Friedland G;
    Clin Infect Dis; 2008 Mar; 46(6):941-5. PubMed ID: 18279044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 13th annual HIV drug guide.
    Djuricich P; Vázquez E
    Posit Aware; 2009; 20(2):28-55. PubMed ID: 19280745
    [No Abstract]   [Full Text] [Related]  

  • 24. 12th annual HIV drug guide.
    Diaz-Linares M; Vázquez E; Gallant J; Delaney M
    Posit Aware; 2008; 19(1):19-48. PubMed ID: 18546577
    [No Abstract]   [Full Text] [Related]  

  • 25. Protease inhibitor combination.
    AIDS Patient Care STDS; 1996 Feb; 10(1):50. PubMed ID: 11361664
    [No Abstract]   [Full Text] [Related]  

  • 26. Pregnancy danger.
    Posit Aware; 1998; 9(5):18. PubMed ID: 11365886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Peripheral lipodystrophy associated with protease inhibitor therapy].
    Cabot de Vega E; Fontecha Gómez BJ; Solé Arnau R; Pedrol Clotet E
    Rev Clin Esp; 1999 Aug; 199(8):546-7. PubMed ID: 10522441
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II/III Trials of Viracept start.
    AIDS Patient Care STDS; 1996 Jun; 10(3):187. PubMed ID: 11361632
    [No Abstract]   [Full Text] [Related]  

  • 29. Cohort studies: what do they tell us?
    Chêne G
    J HIV Ther; 2001 May; 6(2):28-31. PubMed ID: 11501200
    [No Abstract]   [Full Text] [Related]  

  • 30. [Are all boosted protease inhibitors the same? Previously treated patients profit too from lopinavir/r].
    MMW Fortschr Med; 2003 Dec; 145(50):61. PubMed ID: 14963981
    [No Abstract]   [Full Text] [Related]  

  • 31. A nuke-free regimen.
    TreatmentUpdate; 2003; 15(2):7-8. PubMed ID: 12693364
    [No Abstract]   [Full Text] [Related]  

  • 32. [Facial lipodystrophy in patients with HIV infections troublesome to treat].
    Walther RA
    Lakartidningen; 2002 Sep; 99(39):3826-9. PubMed ID: 12395531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Indinavir-associated lipodystrophy].
    Krautheim A
    Praxis (Bern 1994); 1999 Feb; 88(7):285-7. PubMed ID: 10097649
    [No Abstract]   [Full Text] [Related]  

  • 34. [Individualized therapy with fosamprenavir/r. A PI suitable in liver problems].
    MMW Fortschr Med; 2008 Apr; 150 Spec No 1():60-1. PubMed ID: 19031566
    [No Abstract]   [Full Text] [Related]  

  • 35. Merck pushes the envelope with once-daily indinavir.
    TreatmentUpdate; 2001; 12(12):8. PubMed ID: 11570096
    [No Abstract]   [Full Text] [Related]  

  • 36. [Progress toward a once daily regimen. (HA)ART--the art of antiretroviral therapy].
    MMW Fortschr Med; 2001 Apr; 143 Suppl 1():78-9. PubMed ID: 11373790
    [No Abstract]   [Full Text] [Related]  

  • 37. Adverse drug reactions to protease inhibitors.
    Manchanda T; Schiedel D; Fischer D; Dekaban GA; Rieder MJ
    Can J Clin Pharmacol; 2002; 9(3):137-46. PubMed ID: 12422251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-HIV agents. Leading to lipodystrophy.
    TreatmentUpdate; 2007 Feb; 19(2):3-4. PubMed ID: 17447312
    [No Abstract]   [Full Text] [Related]  

  • 39. [Interview with Prof. Reinhold E. Schmidt. Important selection criteria: tolerance and simplicity]].
    Schmidt RE
    MMW Fortschr Med; 2005 Apr; 147 Spec No 1():84-5. PubMed ID: 16385889
    [No Abstract]   [Full Text] [Related]  

  • 40. Double jeopardy: the hazards of drug-drug interactions.
    Flexner C
    Res Initiat Treat Action; 1998 Dec; 4(7):3-8. PubMed ID: 11366084
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.